Structural Formula (Ery05 0003 01)
Erythromycin Lactobionate
Product Images NDC 14789-116
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Erythromycin Lactobionate (NDC 14789-116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nexus Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Ery05 0003 02)
Figure (Ery05 0003 03)
Erythromycin Lactobionate for Injection is a sterile powder for intravenous use only. It is benzyl alcohol-free and when mixed as directed produces a concentration of 50 mg of erythromycin activity per mL. Each vial contains erythromycin lactobionate equivalent to 500 mg of erythromycin. The initial solution is stable for two weeks in the refrigerator or 24 hours at room temperature. The initial dilution should be prepared with 10mL of sterile water for injection without preservatives. Storage temperature should be between 20°C to 25°C. The product is manufactured in Germany for Nexus Pharmaceuticals, Inc., Lincolnshire, IL, USA.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
